Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $1.6 million.

  • HeartSciences' Total Current Liabilities fell 5257.27% to $1.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.6 million, marking a year-over-year decrease of 5257.27%. This contributed to the annual value of $3.7 million for FY2025, which is 11139.86% up from last year.
  • Latest data reveals that HeartSciences reported Total Current Liabilities of $1.6 million as of Q4 2025, which was down 5257.27% from $3.0 million recorded in Q3 2025.
  • HeartSciences' 5-year Total Current Liabilities high stood at $3.7 million for Q2 2025, and its period low was $1.1 million during Q2 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $1.9 million (2023), whereas its average is $2.4 million.
  • In the last 5 years, HeartSciences' Total Current Liabilities soared by 21160.83% in 2022 and then tumbled by 5257.27% in 2025.
  • HeartSciences' Total Current Liabilities (Quarter) stood at $1.1 million in 2021, then soared by 181.82% to $3.1 million in 2022, then grew by 12.5% to $3.5 million in 2023, then dropped by 6.47% to $3.3 million in 2024, then plummeted by 52.57% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, $3.0 million for Q3 2025, and $3.7 million during Q2 2025.